Related Experiment Video
Updated: May 13, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Chromosomal Instability and Clonal Heterogeneity in Breast Cancer: From Mechanisms to Clinical Applications
María Paula Meléndez-Flórez1, Oscar Ortega-Recalde1,2, Nelson Rangel3
1Departamento de Morfología, Facultad de Medicina e Instituto de Genética, Universidad Nacional de Colombia, Bogotá 110231, Colombia.
Chromosomal instability (CIN) and clonal heterogeneity (CH) drive breast cancer progression and resistance. Understanding these hallmarks is key for developing new diagnostic and therapeutic strategies in precision medicine.
Area of Science:
- Oncology
- Genetics
- Cancer Biology
Background:
- Chromosomal instability (CIN) and clonal heterogeneity (CH) are core features of breast cancer.
- These phenomena significantly influence tumor evolution, disease advancement, and resistance to therapies.
- Elucidating the mechanisms behind CIN and CH is crucial for enhancing breast cancer management.
Purpose of the Study:
- To provide a comprehensive review of biological processes contributing to CIN and CH in breast cancer.
- To highlight the molecular drivers and clinical significance of CIN and CH.
- To integrate recent findings on the impact and translational implications of CIN and CH for precision medicine.
Main Methods:
- Literature review synthesizing current knowledge on CIN and CH in breast cancer.
- Discussion of advanced detection methods, including single-cell sequencing.
- Exploration of the influence of CIN and CH on treatment responses and the tumor immune microenvironment.
Main Results:
- Advances in high-resolution techniques, such as single-cell sequencing, improve the characterization of intratumoral heterogeneity.
- CIN and CH impact treatment efficacy and can be modulated within the tumor immune microenvironment.
- These hallmarks have significant implications for the effectiveness of immunotherapies.
Conclusions:
- CIN and CH are critical factors in breast cancer progression and therapeutic resistance.
- Understanding these processes offers translational opportunities for precision medicine approaches.
- Targeting CIN and CH may represent novel therapeutic strategies for breast cancer.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

